45. Eosinophilic granulomatosis with Polyangiitis
27 clinical trials,   41 drugs   (DrugBank: 18 drugs),   18 drug target genes,   98 drug target pathways
Searched query = "Eosinophilic granulomatosis with Polyangiitis", "EGPA", "Eosinophilic multiple vasculitis granulomatous disease", "Allergic granulomatous angiitis", "Churg-Strauss syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | JPRN-JapicCTI-060242 | 01/2/2006 | Phase 3 study of GGS in patients with CSS/AGA | Double-blind, Randomized clinical study of GGS (Intravenous Immunoglobulin) in patients with CSS/AGA. Phase 3 study. | Churg-Strauss Syndrome (CSS) / Allergic Granulomatous Angiitis (AGA) | Intervention name : Freeze-Dried Sulfonated Human Normal Immunoglobulin (GGS) Dosage And administration of the intervention : Intravenous drip infusion Control intervention name : Placebo (physiological saline) Dosage And administration of the control intervention : Intravenous drip infusion | TEIJIN PHARMA LIMITED | NULL | 20 | 74 | BOTH | 21 | Phase 3 | NULL |